FDA Inspection
Zhejiang Huahai PharmaceuticalZhejiang Huahai Pharmaceutical – FDA Inspection, May 19, 2017
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical, with an inspection on May 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b372541c-3043-4904-ac57-0ba2c3b72570
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012805
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Huahai Pharmaceutical
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2024 | Not classified | Office of Inspections and Investigations | |
| July 29, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Huahai Pharmaceutical
- FDA Inspection 1255905 - 2024-11-20
- FDA Inspection 1150702 - 2021-07-29
- FDA Inspection 1062283 - 2018-08-03
- FDA Inspection 886530 - 2014-05-23
- FDA Inspection 712157 - 2010-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.